Repligen Corp (NASDAQ:RGEN) shares, rose in value on Friday, March 28, with the stock price down by -2.71% to the previous day’s close as strong demand from buyers drove the stock to $133.41.
Actively observing the price movement in the last trading, the stock closed the session at $137.12, falling within a range of $130.41 and $136.87. The value of beta (5-year monthly) was 0.951. Referring to stock’s 52-week performance, its high was $187.25, and the low was $113.50. On the whole, RGEN has fluctuated by -14.78% over the past month.
With the market capitalization of Repligen Corp currently standing at about $7.49 billion, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Feb-19.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 698.38M, with a low estimate of 158.1M and a high estimate of 166.8M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 163.46M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that RGEN’s technical picture suggests that short-term indicators denote the stock is a 50% Sell on average. However, medium-term indicators have put the stock in the category of 50% Buy while long-term indicators on average have been pointing out that it is a 50% Sell.
The stock’s technical analysis shows that the price of RGEN currently trading nearly -8.77% and -13.66% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 37.13, while the 7-day volatility ratio is showing 4.04% which for the 30-day chart, stands at 5.42%. Furthermore, Repligen Corp (RGEN)’s beta value is 1.24, and its average true range (ATR) is 7.56.
A comparison of Repligen Corp (RGEN) with its peers suggests the former has fared considerably weaker in the market. RGEN showed an intraday change of -2.71% in last session, and over the past year, it shrunk by -27.43%%.
Data on historical trading for Repligen Corp (NASDAQ:RGEN) indicates that the trading volumes over the past 10 days have averaged 0.67 and over the past 3 months, they’ve averaged 630.41K. According to company’s latest data on outstanding shares, there are 56.09 million shares outstanding.
Nearly 5.57% of Repligen Corp’s shares belong to company insiders and institutional investors own 100.75% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 3.8 million shares as on 2025-03-14, resulting in a short ratio of 4.89. According to the data, the short interest in Repligen Corp (RGEN) stood at 790.00 of shares outstanding as of 2025-03-14; the number of short shares registered in 2025-02-14 reached 3.25 million. The stock has fallen by -7.32% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the RGEN stock heading into the next quarter.
